AstraZeneca: all 4,196 studies
Page 40 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild AsthmaCompletedNCT00288379Phase 3
- Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.CompletedNCT00287534Phase 2
- ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 YearsCompletedNCT00286117Phase 3
- Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal CancerCompletedNCT00284817Phase 1/2
- GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesCompletedNCT00280865Phase 2
- Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderCompletedNCT00278941Phase 3
- Effect of Budesonide / Formoterol Combination in Repeated AMP ProvocationsCompletedNCT00272753Phase 4
- SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast CancerCompletedNCT00272740Phase 2
- Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and CaregiverCompletedNCT00272727Not applicable
- Esomeprazole in PPI Failures - IMPROVECompletedNCT00272701Phase 4
- Trial of Iressa in Prostate Cancer PatientsCompletedNCT00265070Phase 2
- ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin SensitivityTerminatedNCT00263965Phase 2
- Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid TumorsCompletedNCT00263783Phase 1
- Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA PositiveCompletedNCT00263744Phase 1/2
- A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusCompletedNCT00263276Phase 2
- C-Reactive Protein (CRP) in Obese Diabetic WomenCompletedNCT00262548Phase 4
- Dose Response Study in Japanese PatientsTerminatedNCT00261417Phase 2
- GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTerminatedNCT00261352Phase 3
- Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)CompletedNCT00261287Phase 3
- SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00259792Phase 3
- Comparison Between Symbicort® and Prednisolone in COPDCompletedNCT00259779Phase 3
- SHARE - Symbicort and Health Economics in a Real Life EvaluationCompletedNCT00259766Phase 3
- Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCompletedNCT00259077Phase 3
- Iressa v BSC (Best Supportive Care) in First Line NSCLCCompletedNCT00259064Phase 2/3
- A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCompletedNCT00259051Phase 3
- CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior TherapyCompletedNCT00257205Phase 3
- Sopran - Omeprazole Treatment Versus SurgeryCompletedNCT00256737Phase 3
- Phase II Iressa Versus Vinorelbine (INVITE)CompletedNCT00256711Phase 2
- G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)TerminatedNCT00255645
- GALLANT 4 Tesaglitazar vs. GlibenclamideTerminatedNCT00255541Phase 3
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric SubjectsCompletedNCT00255528Phase 3
- Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With SchizophreniaCompletedNCT00255515Phase 4
- 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric SubjectsCompletedNCT00255502Phase 3
- A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung CancerCompletedNCT00255489Phase 1
- The IRESSA Novel Head and Neck Chemotherapy Evaluation StudyCompletedNCT00255476Phase 2
- Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa StudyCompletedNCT00255463Phase 2
- Efficacy and Safety of AZD7009 in the Treatment of Atrial FibrillationCompletedNCT00255281Phase 2
- CMAB vs IMAB in Metastatic Prostate CancerWithdrawnNCT00255268Phase 4
- Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCompletedNCT00255255Phase 3
- Fast Titration Of Quetiapine Versus Currently Approved TitrationCompletedNCT00254813Phase 3
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCompletedNCT00254800Phase 1
- Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic PatientsCompletedNCT00254787Phase 2
- Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid CyclingCompletedNCT00254774Phase 3
- Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered PatientsCompletedNCT00254748Phase 2
- Quetiapine Augmentation in Severe Obsessive Compulsive DisorderCompletedNCT00254735Phase 3
- Study of CP-675,206 in Refractory MelanomaCompletedNCT00254579Phase 2
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes MellitusCompletedNCT00254254Phase 2
- Safety and Efficacy of Seroquel in First Episode SchizophreniaCompletedNCT00254241Phase 4
- GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesTerminatedNCT00252876Phase 3
- DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsCompletedNCT00252863Phase 3
- GALLANT 22 Tesaglitazar vs. PlaceboTerminatedNCT00252837Phase 3
- STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent AsthmaCompletedNCT00252824Phase 3
- A Study of ZD1839 Effects on Cell Proliferation in Breast CancerWithdrawnNCT00252811Phase 2
- ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung CancerCompletedNCT00252798Phase 1
- Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsCompletedNCT00252785Phase 3
- GALLANT 2 Tesaglitazar vs. PlaceboTerminatedNCT00252772Phase 3
- Iressa Case Control Study in JapanCompletedNCT00252759
- Iressa 2nd Line Phase III Study in JapanCompletedNCT00252707Phase 3
- Nexium Dyspepsia/ASTCompletedNCT00251992Phase 3
- ASTERIX: Low Dose ASA and NexiumCompletedNCT00251966Phase 3
- GALLANT 8 Tesaglitazar Add-on to MetforminTerminatedNCT00251953Phase 3
- GALLANT 7 Tesaglitazar Add-on to SulphonylureaTerminatedNCT00251940Phase 3
- Nexium Dyspepsia/ASTCompletedNCT00251914Phase 3
- Chest Pain Pilot StudyCompletedNCT00251901Phase 3
- ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast CancerCompletedNCT00247481Phase 2
- Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCTCompletedNCT00246974Phase 2
- Arimidex Observational: Reason for and Effect of Change From TamoxifenCompletedNCT00246961
- Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)CompletedNCT00246935Phase 3
- Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07).CompletedNCT00246922Phase 3
- Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of AgeCompletedNCT00244634Phase 3
- A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®CompletedNCT00244608Phase 3
- Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of AgeCompletedNCT00244595Phase 3
- HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCompletedNCT00243724Phase 3
- Iressa vs Best Supportive Care - 2nd/3rd Line Survival StudyCompletedNCT00242801Phase 3
- IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
- Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgCompletedNCT00242775Phase 3
- ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCompletedNCT00242762Phase 2
- IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck CarcinomaCompletedNCT00242749Phase 2
- An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00242736Phase 4
- MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00242411Phase 4
- GALLANT 9 Tesaglitazar vs. Placebo in Combination With InsulinTerminatedNCT00242372Phase 3
- High Doses of Candesartan Cilexetil on the Reduction of ProteinuriaCompletedNCT00242346Phase 3
- Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)CompletedNCT00242320Phase 3
- Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05).CompletedNCT00242307Phase 2/3
- Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)CompletedNCT00242294Phase 2/3
- Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241553Phase 3
- Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241540Phase 3
- Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241527Phase 3
- Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241514Phase 3
- Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent PatientsCompletedNCT00241501Phase 3
- DISCOVERY Asia - Crestor in Type IIa and IIb HypercholesteremiaCompletedNCT00241488Phase 3
- Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or RadiotherapyCompletedNCT00241475Phase 2
- Faslodex Observations During Regular Use by Advanced Mammacarcinoma PatientsTerminatedNCT00241462
- A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast CancerCompletedNCT00241449Phase 3
- Open Label Arimidex in GynecomastiaCompletedNCT00241436Phase 2
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesCompletedNCT00241423Phase 2
- A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)CompletedNCT00240929Phase 2
- Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)CompletedNCT00240877Phase 3
- Effect of an Internet Based Compliance Enhancement Tool in Subjects With HypercholesterolemiaWithdrawnNCT00240357Phase 4
- Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target GoalCompletedNCT00240344